Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study finds better pain block for elderly hip replacement patients

NCT ID NCT06679764

Symptom relief Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two types of nerve blocks to control pain after total hip replacement in 93 older adults (65+). The goal was to see which block reduced the need for morphine and improved movement. Results showed which block worked better for pain relief and recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

93 people

The number who actually took part.

Started

May 2022

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Both genders * Type of surgery; unilateral elective total hip replacement. * Physical status ASA I- III * Age ≥ 65 Years. * Body mass index (BMI): \> 20 kg/m2 and \< 35 kg/m2. * Traumatic fracture hip through anterolateral approach. Exclusion Criteria: * Patient refusal. * Patients with known sensitivity or contraindication to drugs used in the study (local anesthetics \& opioids). * History of psychological disorders and/or chronic pain. * Pre- existing peripheral neuropathies * Coagulopathy. * Infection of the skin at the site of needle puncture area. * Active cardiac condition (unstable coronary syndromes, significant arrhythmias, severe valvular disease). * Acute respiratory disease (active chest infection, respiratory failure). * Advanced liver disease (increased liver enzymes \>3 folds) or severe kidney disease (creatinine \>2). * long operative time more than 3 hours.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hip fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post operative analgesia

Contacts and locations

Locations

  • Faculty of Medicine, Cairo University

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.